Pharmaceutical Technology

FEBRUARY 22, 2023

Amgen could be the winner of a high-stakes patent spat with Sanofi as tensions run high weeks before the March 27 US Supreme Court hearing. While some courts were previously on Sanofi’s side, it is possible that Amgen’s case could win this time, some legal experts say. Both drugs come with a high price tag.

Pharma 104

Pharma Government FDA Sales 104

Pharmaceutical Technology

FEBRUARY 10, 2023

This is not the first treatment to come with a high price tag. For example, in Sweden, the proposed arrangement for Sanofi / Regeneron’s Dupixent (dupilumab) included a tripartite price negotiation involving Sanofi, the Dental and Pharmaceutical Benefits Agency (Tandvårds- och läkemedelsförmånsverket, TLV), and local councils.

Marketing 105

Marketing Medicine Leads Safety 105

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Medicine 52

pharmaphorum

NOVEMBER 28, 2022

Owkin in particular has bagged some high-profile, high-price tag development deals with the likes of Bristol-Myers Squibb and Sanofi. A number of companies have sprung up offering AI models to help pharma companies with drug discovery over the past few years.

Training 72

Training Medical Pharma Healthcare 72

Pharmaceutical Technology

JANUARY 27, 2023

On January 18, Sanofi launched a new warranty program for its rare blood disorder drug Cablivi (caplacizumab), which tackles value-based agreements in a slightly different way. The post Sanofi offers refunds for Cablivi in novel model for rebates appeared first on Pharmaceutical Technology.

Patients 52

Patients Pharmaceutical Manufacturing Healthcare Provider 52

PM360

APRIL 7, 2023

This option grows more critical as new therapies become available with price tags as high as $3.5 Sanofi Promises Money Back for Discontinued Blood Disorder Treatment – In Some Cases.” million for the new hemophilia gene therapy. Biotechnology Innovation Organization, February 16, 2021. Naddaf, Miryam. “$3.5-Million DeFeudis, Nicole.

Manufacturing 52

Manufacturing Marketing Patients Safety 52